Abstract
Bariatric surgeries can help resolve metabolic derangements concomitant to obesity; therefore, they are now referred to as metabolic surgeries. Duodenojejunal bypass (DJB) is a new procedure of metabolic surgery relying on foregut hypothesis. DJB has been described as a standalone procedure to treat non-obese diabetic patients; however, performed in combination with sleeve gastrectomy (LDJB/SG) for obese subjects. Literature review revealed fi fty-nine patients undergoing LDJB/SB in three clinical studies. Operation time, complication rates, improvements in preoperative comorbidities, and weight reduction in these subjects were assessed. The effect of LDJB/SG on type 2 diabetes was observed to range from 70% to 92.9% while it improved hypertension by 80% to 85.7% and hyperlipidemia by 100%. Obese patients lost nearly 80% of their excess weights. LDJB/SG is a safe and effective procedure to maintain weight loss in the long-term and achieve perfect outcomes in comorbidity improvement. However, there is a need for long-term follow-up studies.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
